175 related articles for article (PubMed ID: 9464837)
1. Processing of exogenous hepatitis B surface antigen particles for Ld-restricted epitope presentation depends on exogenous beta2-microglobulin.
Schirmbeck R; Thoma S; Reimann J
Eur J Immunol; 1997 Dec; 27(12):3471-84. PubMed ID: 9464837
[TBL] [Abstract][Full Text] [Related]
2. 'Empty' Ld molecules capture peptides from endocytosed hepatitis B surface antigen particles for major histocompatibility complex class I-restricted presentation.
Schirmbeck R; Reimann J
Eur J Immunol; 1996 Dec; 26(12):2812-22. PubMed ID: 8977273
[TBL] [Abstract][Full Text] [Related]
3. Processing of exogenous heat-aggregated (denatured) and particulate (native) hepatitis B surface antigen for class I-restricted epitope presentation.
Schirmbeck R; Böhm W; Melber K; Reimann J
J Immunol; 1995 Nov; 155(10):4676-84. PubMed ID: 7594467
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis B virus small surface antigen particles are processed in a novel endosomal pathway for major histocompatibility complex class I-restricted epitope presentation.
Schirmbeck R; Melber K; Reimann J
Eur J Immunol; 1995 Apr; 25(4):1063-70. PubMed ID: 7537671
[TBL] [Abstract][Full Text] [Related]
5. Priming MHC-I-restricted cytotoxic T lymphocyte responses to exogenous hepatitis B surface antigen is CD4+ T cell dependent.
Wild J; Grusby MJ; Schirmbeck R; Reimann J
J Immunol; 1999 Aug; 163(4):1880-7. PubMed ID: 10438922
[TBL] [Abstract][Full Text] [Related]
6. Dendritic cells pulsed with exogenous hepatitis B surface antigen particles efficiently present epitopes to MHC class I-restricted cytotoxic T cells.
Stober D; Trobonjaca Z; Reimann J; Schirmbeck R
Eur J Immunol; 2002 Apr; 32(4):1099-108. PubMed ID: 11920577
[TBL] [Abstract][Full Text] [Related]
7. Factors affecting the presentation of exogenous hepatitis B virus core antigen.
Devasahayam M
Indian J Exp Biol; 2007 Aug; 45(8):689-95. PubMed ID: 17877145
[TBL] [Abstract][Full Text] [Related]
8. Recognition of a shared human prostate cancer-associated antigen by nonclassical MHC-restricted CD8+ T cells.
Housseau F; Bright RK; Simonis T; Nishimura MI; Topalian SL
J Immunol; 1999 Dec; 163(11):6330-7. PubMed ID: 10570328
[TBL] [Abstract][Full Text] [Related]
9. Exogenous hepatitis B surface antigen particles processed by dendritic cells or macrophages prime murine MHC class I-restricted cytotoxic T lymphocytes in vivo.
Böhm W; Schirmbeck R; Elbe A; Melber K; Diminky D; Kraal G; van Rooijen N; Barenholz Y; Reimann J
J Immunol; 1995 Oct; 155(7):3313-21. PubMed ID: 7561024
[TBL] [Abstract][Full Text] [Related]
10. The T/B cell interaction involved in induction of the mouse IgG2ab suppression is restricted by major histocompatibility complex class I, but not class II molecules.
Majlessi L; Bordenave G
Eur J Immunol; 1997 Jun; 27(6):1346-52. PubMed ID: 9209483
[TBL] [Abstract][Full Text] [Related]
11. Beta 2-microglobulin independent presentation of exogenously added foreign peptide and endogenous self-epitope by MHC class I alpha-chain to a cross-reactive CD8+ CTL clone.
Zügel U; Schoel B; Kaufmann SH
J Immunol; 1994 Nov; 153(9):4070-80. PubMed ID: 7523514
[TBL] [Abstract][Full Text] [Related]
12. Selective killing of hepatitis B envelope antigen-specific B cells by class I-restricted, exogenous antigen-specific T lymphocytes.
Barnaba V; Franco A; Alberti A; Benvenuto R; Balsano F
Nature; 1990 May; 345(6272):258-60. PubMed ID: 2110296
[TBL] [Abstract][Full Text] [Related]
13. Phagocytic processing of exogenous particulate antigens by macrophages for presentation by class I MHC molecules.
Harding CV; Song R
J Immunol; 1994 Dec; 153(11):4925-33. PubMed ID: 7963555
[TBL] [Abstract][Full Text] [Related]
14. Targeting of exogenous protein antigens to a novel endosomal processing pathway for class I-restricted presentation.
Schirmbeck R; Reimann J
Behring Inst Mitt; 1994 Dec; (95):14-22. PubMed ID: 7755505
[TBL] [Abstract][Full Text] [Related]
15. Sensitization of MHC class I-restricted T cells to exogenous proteins: evidence for an alternative class I-restricted antigen presentation pathway.
Martinez-Kinader B; Lipford GB; Wagner H; Heeg K
Immunology; 1995 Oct; 86(2):287-95. PubMed ID: 7490131
[TBL] [Abstract][Full Text] [Related]
16. Trypanosoma cruzi infection does not impair major histocompatibility complex class I presentation of antigen to cytotoxic T lymphocytes.
Buckner FS; Wipke BT; Van Voorhis WC
Eur J Immunol; 1997 Oct; 27(10):2541-8. PubMed ID: 9368608
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of MHC class I-restricted antigen processing and cross-presentation.
Cresswell P; Ackerman AL; Giodini A; Peaper DR; Wearsch PA
Immunol Rev; 2005 Oct; 207():145-57. PubMed ID: 16181333
[TBL] [Abstract][Full Text] [Related]
18. Principles of MHC class I-mediated antigen presentation and T cell selection.
Ljunggren HG; Thorpe CJ
Histol Histopathol; 1996 Jan; 11(1):267-74. PubMed ID: 8720469
[TBL] [Abstract][Full Text] [Related]
19. Bacterial antigen delivery systems: phagocytic processing of bacterial antigens for MHC-I and MHC-II presentation to T cells.
Svensson M; Pfeifer J; Stockinger B; Wick MJ
Behring Inst Mitt; 1997 Feb; (98):197-211. PubMed ID: 9382741
[TBL] [Abstract][Full Text] [Related]
20. Two processing pathways for the MHC class II-restricted presentation of exogenous influenza virus antigen.
Pinet V; Malnati MS; Long EO
J Immunol; 1994 May; 152(10):4852-60. PubMed ID: 8176208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
